CL2014001137A1 - Compuestos derivados de [biciclo[2.2.1]heptano-2,1’-coclobutano]amina, moduladores no competitivos de los receptores nicotinicos; composicion farmaceutica; y metodo para tratar o prevenir una enfermedad o condicion tal como ibs-d, oab, adiccion a la nicotina, dejar de fumar, depresion, trastorno depresivo mayor o hipertension. - Google Patents
Compuestos derivados de [biciclo[2.2.1]heptano-2,1’-coclobutano]amina, moduladores no competitivos de los receptores nicotinicos; composicion farmaceutica; y metodo para tratar o prevenir una enfermedad o condicion tal como ibs-d, oab, adiccion a la nicotina, dejar de fumar, depresion, trastorno depresivo mayor o hipertension.Info
- Publication number
- CL2014001137A1 CL2014001137A1 CL2014001137A CL2014001137A CL2014001137A1 CL 2014001137 A1 CL2014001137 A1 CL 2014001137A1 CL 2014001137 A CL2014001137 A CL 2014001137A CL 2014001137 A CL2014001137 A CL 2014001137A CL 2014001137 A1 CL2014001137 A1 CL 2014001137A1
- Authority
- CL
- Chile
- Prior art keywords
- coclobutane
- oab
- ibs
- bicyclo
- hypertension
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/38—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161554998P | 2011-11-03 | 2011-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014001137A1 true CL2014001137A1 (es) | 2014-08-18 |
Family
ID=48193026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014001137A CL2014001137A1 (es) | 2011-11-03 | 2014-04-30 | Compuestos derivados de [biciclo[2.2.1]heptano-2,1’-coclobutano]amina, moduladores no competitivos de los receptores nicotinicos; composicion farmaceutica; y metodo para tratar o prevenir una enfermedad o condicion tal como ibs-d, oab, adiccion a la nicotina, dejar de fumar, depresion, trastorno depresivo mayor o hipertension. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20140288185A1 (es) |
| EP (1) | EP2773609A4 (es) |
| JP (1) | JP2014532708A (es) |
| KR (1) | KR20140098115A (es) |
| AU (1) | AU2012332545A1 (es) |
| BR (1) | BR112014010719A2 (es) |
| CA (1) | CA2853282A1 (es) |
| CL (1) | CL2014001137A1 (es) |
| IL (1) | IL232240A0 (es) |
| MX (1) | MX2014005216A (es) |
| RU (1) | RU2014122338A (es) |
| SG (1) | SG11201401984VA (es) |
| WO (1) | WO2013067105A2 (es) |
| ZA (1) | ZA201403502B (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3290215A (en) * | 1963-10-29 | 1966-12-06 | Du Pont | Use of methanoindanamines as antiviral agents |
| US3317387A (en) * | 1964-05-25 | 1967-05-02 | Du Pont | Method of reducing the severity of influenza virus infections |
| TW200306189A (en) * | 2002-03-21 | 2003-11-16 | Merz Pharma Gmbh & Co Kgaa | Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
| US8809397B2 (en) * | 2010-05-27 | 2014-08-19 | Targacept, Inc. | Nicotinic receptor non-competitive antagonists |
-
2012
- 2012-11-01 MX MX2014005216A patent/MX2014005216A/es not_active Application Discontinuation
- 2012-11-01 RU RU2014122338/04A patent/RU2014122338A/ru not_active Application Discontinuation
- 2012-11-01 JP JP2014540061A patent/JP2014532708A/ja active Pending
- 2012-11-01 CA CA2853282A patent/CA2853282A1/en not_active Abandoned
- 2012-11-01 EP EP12846619.0A patent/EP2773609A4/en not_active Withdrawn
- 2012-11-01 SG SG11201401984VA patent/SG11201401984VA/en unknown
- 2012-11-01 WO PCT/US2012/062940 patent/WO2013067105A2/en active Application Filing
- 2012-11-01 KR KR1020147015185A patent/KR20140098115A/ko not_active Application Discontinuation
- 2012-11-01 BR BR112014010719A patent/BR112014010719A2/pt not_active Application Discontinuation
- 2012-11-01 AU AU2012332545A patent/AU2012332545A1/en not_active Abandoned
- 2012-11-01 US US14/355,316 patent/US20140288185A1/en not_active Abandoned
-
2014
- 2014-04-24 IL IL232240A patent/IL232240A0/en unknown
- 2014-04-30 CL CL2014001137A patent/CL2014001137A1/es unknown
- 2014-05-14 ZA ZA2014/03502A patent/ZA201403502B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013067105A2 (en) | 2013-05-10 |
| WO2013067105A3 (en) | 2013-07-11 |
| EP2773609A2 (en) | 2014-09-10 |
| IL232240A0 (en) | 2014-06-30 |
| MX2014005216A (es) | 2014-08-22 |
| KR20140098115A (ko) | 2014-08-07 |
| JP2014532708A (ja) | 2014-12-08 |
| ZA201403502B (en) | 2015-12-23 |
| AU2012332545A1 (en) | 2014-05-29 |
| RU2014122338A (ru) | 2015-12-10 |
| SG11201401984VA (en) | 2014-05-29 |
| CA2853282A1 (en) | 2013-05-10 |
| US20140288185A1 (en) | 2014-09-25 |
| BR112014010719A2 (pt) | 2017-05-02 |
| EP2773609A4 (en) | 2015-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016500777B1 (en) | Compositions and methods for modulating farnesoid x receptors | |
| MX2021015234A (es) | Composiciones y metodos que comprenden bupropion o compuestos relacionados y dextrometorfano. | |
| CL2013003042A1 (es) | Compuestos derivados metilamina de biciclos sustituidos, moduladores de receptores de esfingosin-1- fosfato; composicion farmaceutica; y un metodo de tratamiento para tratar enfermedades oculares, degeneracion macular, retinopatia, entre otros | |
| CR20150114A (es) | Composición farmacéutica recubierta que contiene regorafenib | |
| MX2013014978A (es) | Metodo para la administracion de 4-((1r,3s)-6-cloro-3-fenil-indan- 1-il)-1,2,2-trimetil-piperazina y de sus sales en el tratamiento de esquinozofrenia. | |
| EA201592256A1 (ru) | Производные имидазопирролидинона и их применение при лечении заболеваний | |
| EA201690223A1 (ru) | Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение | |
| EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
| UY33370A (es) | Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización | |
| AR089670A1 (es) | Forma de dosificacion que comprende nicotina solida con reduccion de los trastornos organolepticos | |
| ECSP13013087A (es) | Compuestos para el tratamiento de la adicción | |
| ME01185B (me) | Derivati alkaloidnih aminoestara i njihovi ljekoviti preparati | |
| EA201290552A1 (ru) | Способ производства фармацевтически активного вещества | |
| ECSP13012847A (es) | Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxi-quinazolin-6-iloxi]-1,4-diaza-espiro[5.5]undecan-5-ona, su uso como medicamento y su preparación. | |
| BR112014002845A2 (pt) | composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto | |
| SV2017005603A (es) | Formulacion solida oral que contiene irinotecan y metodo de preparacion de la misma | |
| EA201400064A1 (ru) | Офтальмологическая фармацевтическая композиция для местного применения, которая содержит регорафениб | |
| EP2687216A4 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES ASSOCIATED WITH AGING, CONTAINING AS AN ACTIVE INGREDIENT PROGERIN EXPRESSION INHIBITOR, AND SCREENING METHOD FOR SEARCHING FOR PROGERIN EXPRESSION INHIBITOR | |
| AR084882A1 (es) | Compuesto de 1-azabiciclo[2.2.2]octano y usos para el tratamiento de esquizofrenia | |
| CL2012003274A1 (es) | Compuestos derivados de espiro[biciclo[2.2.1]heptano-2,1-(ciclobutano o ciclopentano) y espiro- ([biciclo]oct[5]eno o biciclo[2.2.2]octano)-2,1-ciclopentano, moduladores de receptores nicotinicos; composicion farmaceutica; utiles en el tratamiento de enfermedades o condicion ibs-d, oab, adiccion a la nicotina, depresion, entre otros. | |
| CL2014001137A1 (es) | Compuestos derivados de [biciclo[2.2.1]heptano-2,1’-coclobutano]amina, moduladores no competitivos de los receptores nicotinicos; composicion farmaceutica; y metodo para tratar o prevenir una enfermedad o condicion tal como ibs-d, oab, adiccion a la nicotina, dejar de fumar, depresion, trastorno depresivo mayor o hipertension. | |
| UY34080A (es) | Composición farmacéutica para administración oral que comprende fexofenadina y métodos de preparación | |
| WO2013188465A3 (en) | Treating drug addiction and preventing drug relapse | |
| TR201009396A2 (tr) | Desloratadin granüller | |
| DOP2015000049A (es) | Composición farmacéutica recubierta que contiene regorafenib |